You know what's really incredible. Pfizer were willing to pay $142 million + royalies for TT034 when it was still in the very early stages. They also paid for all the preclinical R&D from 2008 which must have cost millions. BLT have either just bought a multi-billion dollar drug for less than $1.5 million (and the company itself) or a dog. The work with non-human primates looked very good and I couldn't understand why you wouldn't take this further. However, I am far from an expert on the science so there has to be a reason why Pfizer didn't take it further. Right??
BLT Price at posting:
37.5¢ Sentiment: Hold Disclosure: Held
